Omnicell (OMCL) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Omnicell (OMCL) Completes Avantec Healthcare Acquisition; Boosts FY15 Revenue Outlook
April 30, 2015 8:21 AM EDTOmnicell (NASDAQ: OMCL) has completed its acquisition of Avantec Healthcare Limited based in Lancing, West Sussex, United Kingdom.
Avantec develops medication and supply automation products that complement Omnicell solutions for configurations uniquely suited to the U.K. marketplace, and has been the exclusive U.K. distributor of Omnicell solutions since 2005. Avantec has installed over 900 systems in 80 National Health Service (NHS) and private hospitals.
This acquisition further demonstrates Omnicell's commitment to supporting the U.K. marketplace. The company purchased U.K. medication adherence packaging provider Surgichem Limited in 2014, and recently completed its acquisition of... More
